Comparative analysis of stress responses of H9c2 rat cardiomyoblasts following treatment with doxorubicin and tBOOH. (Q39408648)

11 September 2017

title

Comparative analysis of stress responses of H9c2 rat cardiomyoblasts following treatment with doxorubicin and tBOOH. (English)

1 reference

11 September 2017

1 reference

Mareike Döhrmann

1

1 reference

11 September 2017

Anne Schorr

2

1 reference

11 September 2017

Johannes Hülsenbeck

3

1 reference

11 September 2017

Tine L Rasmussen

4

1 reference

11 September 2017

Olaf-Georg Issinger

5

1 reference

11 September 2017

Gerhard Fritz

6

1 reference

11 September 2017

language of work or name

English

0 references

publication date

13 January 2012

1 reference

Experimental Cell Research

11 September 2017

published in

1 reference

11 September 2017

volume

318

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

779-788

1 reference

Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Topoisomerase II Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Anthracycline-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Topoisomerase II{alpha}-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Formation and longevity of idarubicin-induced DNA topoisomerase II cleavable complexes in K562 human leukaemia cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Protein kinase CK2 in health and disease: Protein kinase CK2: from structures to insights.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Structural basis of the constitutive activity of protein kinase CK2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Localization of X-ray cross complementing gene 1 protein in the nuclear matrix is controlled by casein kinase II-dependent phosphorylation in response to oxidative damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

XRCC1 phosphorylation by CK2 is required for its stability and efficient DNA repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

A specific inhibitor of protein kinase CK2 delays gamma-H2Ax foci removal and reduces clonogenic survival of irradiated mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

The DNA damage response: ten years after

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

Resorufin: a lead for a new protein kinase CK2 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.010

10.1016/J.YEXCR.2012.01.010

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference